Purpose: Obstruction of the naso-lacrimal duct has traditionally been treat
ed by dacryocystorhinostomy. This pilot project aimed to evaluate the use o
f stents as an alternative approach to the treatment of naso-lacrimal duct
obstruction.
Methods: Six patients with naso-lacrimal duct obstruction underwent a prepr
ocedural dacryocystogram to confirm the site of obstruction. Under local an
aesthesia, they subsequently underwent dilatation of the naso-lacrimal duct
using a guide mire and a plastic dilator aided by fluoroscopy and digital
subtraction imaging. The stent was then placed with its head in the lacrima
l sac and tail protruding out of the naso-lacrimal duct into the inferior m
eatus. Dacryocystography was repeated to confirm patency. Patients mere fol
lowed up for a minimum of 12 months.
Results: The procedure was successfully completed in four of the six patien
ts. In one patient, we failed to negotiate the guide wire and in one, a fal
se passage mas created. All four successful cases mere rendered asymptomati
c and their lacrimal passages remained patent at 12 months.
Conclusion: Naso-lacrimal duct dilatation and stenting is a viable alternat
ive to conventional dacryocystorhinostomy in the treatment of naso-lacrimal
duct obstruction and merits a larger trial.